Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis

Peritoneal Dialysis International

Volumn 28, Issue SUPPL. 5, 2008, Pages

  Witowski, Janusz ^a,b   Ksiazek, Krzysztof ^b   Jörres, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; BETA GALACTOSIDASE; DIALYSIS FLUID; FIBRONECTIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CELL AGING; ENZYME ACTIVITY; HUMAN; MESOTHELIUM CELL; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSING PERITONITIS; SENESCENCE; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EPITHELIUM CELL; FIBROSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERITONEUM; REVIEW; VASCULARIZATION;

ANIMALS; CELL AGING; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FIBROSIS; GLUCOSE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DIALYSIS; PERITONEUM;

EID: 67149136529     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802805s07     Document Type: Article

References (33)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40.
2. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22.
3. Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 2001; 15:458-66.
4. Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002; 1:57-65.
5. Ksiazek K, Mikula-Pietrasik J, Jörres A, Witowski J. Oxidative stress-mediated early senescence contributes to the short replicative lifespan of human peritoneal mesothelial cells. Free Radic Biol Med 2008; 45:460-7.
6. Gotloib L, Shostak A, Wajsbrot V, Kushnier R. High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron 1999; 82: 164-73.
7. Gotloib L, Wajsbrot V, Shostak A. Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine. Free Radic Biol Med 2003; 34:419-28.
8. Arbeiter K, Bidmon B, Endemann M, Bender TO, Eickelberg O, Ruffingshofer D, et al. Peritoneal dialysate fluid composition determines heat shock protein expression patterns in human mesothelial cells. Kidney Int 2001; 60: 1930-7.
9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-7.
10. Gary RK, Kindell SM. Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts. Anal Biochem 2005; 343:329-34.
11. Ksiazek K, Piwocka K, Brzezinska A, Sikora E, Zabel M, Breborowicz A, et al. Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol 2006; 100:988-95.
12. Ksiazek K, Passos JF, Olijslagers S, von Zglinicki T. Mitochondrial dysfunction is a possible cause of accelerated senescence of mesothelial cells exposed to high glucose. Biochem Biophys Res Commun 2008; 366:793-9.
13. Ksiazek K, Breborowicz A, Jörres A, Witowski J. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med 2007; 42: 636-41.
14. Ksiazek K, Korybalska K, Jörres A, Witowski J. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1. Lab Invest 2007; 87:345-56.
15. Ksiazek K, Jörres A, Witowski J. Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuvenation Res 2008; 11:681-3.
16. Margetts PJ, Oh KH, Kolb M. Transforming growth factor-beta: importance in long-term peritoneal membrane changes. Perit Dial Int 2005; 25(Suppl 3):S15-17.
17. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35:644-52.
18. Lin CY, Chen WP, Yang LY, Chen A, Huang TP. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998; 18:513-19.
19. Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2007; 2:251-75.
20. Xie K, Wei D, Shi Q, Huang S. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev 2004; 15:297-324.
21. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-39.
22. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16:425-36.
23. Gunal AI, Duman S, Sen S, Unsal A, Terzioglu E, Akcicek F, et al. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol 2001; 14:184-9.
24. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13:721-8.
25. Nie J, Dou X, Hao W, Wang X, Peng W, Jia Z, et al. Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int 2007; 72:1336-44.
26. Medcalf JF, Walls J, Pawluczyk IZ, Harris KP. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-beta. Nephrol Dial Transplant 2001; 16:1885-92.
27. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63:1404-16.
28. Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22:171-7.
29. Szeto CC, Lai KB, Chow KM, Szeto CY, Wong TY, Li PK. Differential effects of transforming growth factor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell. Nephron Exp Nephrol 2005; 99:e95-104.
30. Haddad JJ. Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 2002; 14:799-810.
31. Noh H, Ha H, Yu MR, Kim YO, Kim JH, Lee HB. Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 2005; 25:38-47.
32. Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 2006; 69:2022-8.
33. Ksiazek K, Passos JF, Olijslagers S, Saretzki G, Martin-Ruiz C, von Zglinicki T. Premature senescence of mesothelial cells is associated with non-telomeric DNA damage. Biochem Biophys Res Commun 2007; 362: 707-11.